首页
400-620-6333
Notch
选项
-
Rovalpituzumab (anti-DLL3)关联靶标: DLL3
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1613313-01-1 -
Brontictuzumab (anti-NOTCH1)关联靶标: NOTCH1
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1447814-75-6 -
Tarextumab (anti-NOTCH3)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG2
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1359940-55-8 -
Demcizumab (anti-DLL4)关联靶标: DLL4
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1243262-17-0 -
Navicixizumab (anti-DLL4)关联靶标: DLL4
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1638338-43-8 -
Enoticumab (anti-DLL4)关联靶标: DLL4
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1192578-27-0 -
Tarlatamab (anti-DLL3&CD3)
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 偶联: Unconjugated
CAS号: 2307488-83-9SMILES: [Tarlatamab]
